Anthony R. Shumate

Array ( [id] => 19430799 [patent_doc_number] => 20240299297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => STABLE EMULSIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/273732 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17759920 [patent_doc_number] => 20220233532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/580768 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18954 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17655232 [patent_doc_number] => 20220175697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => COMPOSITIONS AND METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION [patent_app_type] => utility [patent_app_number] => 17/574705 [patent_app_country] => US [patent_app_date] => 2022-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8443 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17655425 [patent_doc_number] => 20220175890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE [patent_app_type] => utility [patent_app_number] => 17/552325 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18434184 [patent_doc_number] => 20230181478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => Nicotine Tablet [patent_app_type] => utility [patent_app_number] => 17/644182 [patent_app_country] => US [patent_app_date] => 2021-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24989 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17655309 [patent_doc_number] => 20220175774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => Bioavailable Oral Dosage Form Of Tyrosine-Kinase Inhibitor [patent_app_type] => utility [patent_app_number] => 17/542738 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5018 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17928233 [patent_doc_number] => 20220323358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => POWDER FOR ORAL SUSPENSION CONTAINING TADALAFIL [patent_app_type] => utility [patent_app_number] => 17/531222 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17593413 [patent_doc_number] => 20220142986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => HIGH DOSAGE TEBIPENEM PIVOXIL TABLET FORMULATION [patent_app_type] => utility [patent_app_number] => 17/525619 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18363 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18869904 [patent_doc_number] => 11857684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof [patent_app_type] => utility [patent_app_number] => 17/524522 [patent_app_country] => US [patent_app_date] => 2021-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 26651 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17524522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19150121 [patent_doc_number] => 11975011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => Matrix mesalamine extended release minitablets and its process thereof [patent_app_type] => utility [patent_app_number] => 17/517353 [patent_app_country] => US [patent_app_date] => 2021-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5745 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19134504 [patent_doc_number] => 11969413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Pharmaceutical compositions of deutetrabenazine and process for preparation thereof [patent_app_type] => utility [patent_app_number] => 17/510797 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5792 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17525655 [patent_doc_number] => 11298321 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-12 [patent_title] => Methods for treating metabolic disorder [patent_app_type] => utility [patent_app_number] => 17/509215 [patent_app_country] => US [patent_app_date] => 2021-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 43 [patent_no_of_words] => 19696 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17509215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18921351 [patent_doc_number] => 20240024355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => MULTI-LAYERED PARTICLE COMPRISING SIMETHICONE [patent_app_type] => utility [patent_app_number] => 18/255388 [patent_app_country] => US [patent_app_date] => 2021-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17398024 [patent_doc_number] => 20220040114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => Delayed Release Methylphenidate Compositions [patent_app_type] => utility [patent_app_number] => 17/508034 [patent_app_country] => US [patent_app_date] => 2021-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17508034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17383825 [patent_doc_number] => 20220031677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/504133 [patent_app_country] => US [patent_app_date] => 2021-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20371194 [patent_doc_number] => 12478608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Use of slow-releasing hydrogen sulfide organic donor ADT-OH in the preparation of drugs for treating nervous system diseases [patent_app_type] => utility [patent_app_number] => 17/912638 [patent_app_country] => US [patent_app_date] => 2021-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 0 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18366121 [patent_doc_number] => 20230147712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES [patent_app_type] => utility [patent_app_number] => 17/917572 [patent_app_country] => US [patent_app_date] => 2021-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17546666 [patent_doc_number] => 20220118007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => TREATMENT OF ISCHEMIC CONDITIONS, HYPOXIC CONDITIONS, CONDITIONS RELATED TO A HYPOXIA-INDUCTION FACTOR, OR CONDITIONS RELATED TO REACTIVE OXYGEN SPECIES WITH OXYGEN-CONTAINING LIQUIDS [patent_app_type] => utility [patent_app_number] => 17/491863 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17341311 [patent_doc_number] => 20220007642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHODS AND DISINFECTING COVERS FOR USE IN DISINFECTING RESILIENT MEDICAL PATIENT PRESSURE REDISTRIBUTION SUPPORTS [patent_app_type] => utility [patent_app_number] => 17/482742 [patent_app_country] => US [patent_app_date] => 2021-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18806767 [patent_doc_number] => 20230381098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => ORAL DRUG DELIVERY DEVICE WITH EXPANDING ARMS [patent_app_type] => utility [patent_app_number] => 18/245218 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5963 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245218 [rel_patent_id] =>[rel_patent_doc_number] =>)